Topics

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

21:27 EST 14 Feb 2020 | Xconomy

A contraceptive patch developed by Agile Therapeutics was awarded FDA approval late Friday, clearing the way for a new birth control option to reach the market. The Agile (NASDAQ: AGRX) product, called Twirla, deliver delivers a combination of hormones via a proprietary skin patch applied once a week. It’s the first FDA approved product for the […]

Original Article: Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

NEXT ARTICLE

More From BioPortfolio on "Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...